Integra Lifesciences Holdings (IART) Liabilities from Discontinued Operations (2014 - 2022)

Integra Lifesciences Holdings' (IART) quarterly Liabilities from Discontinued Operations came in at 2303000.0 in Q2 2022, down 80.4% quarter-over-quarter from 11751000.0 in Q4 2020.

Integra Lifesciences Holdings (IART) Liabilities from Discontinued Operations (2014 - 2022) Analysis & Trends

Integra Lifesciences Holdings has disclosed Liabilities from Discontinued Operations across 3 years of filings, most recently posting 2303000.0 for Q2 2022.

  • Liabilities from Discontinued Operations for Q2 2022 came in at 2303000.0, changed N/A year-over-year; the trailing twelve-month figure through Jun 2022 was 2303000.0 (changed N/A YoY), and the FY2020 annual result was 11751000.0, changed N/A from the prior year.
  • Liabilities from Discontinued Operations came in at 2303000.0 for Q2 2022 at Integra Lifesciences Holdings, down from 11751000.0 in the prior quarter.
  • In the past five years, Liabilities from Discontinued Operations ranged from a high of 12349000.0 in Q3 2020 to a low of 2303000.0 in Q2 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.92 Bn 146.27 Bn 6.27 Bn
2 Stryker 119.50 Bn 116.62 Bn 3.81 Bn
3 Medtronic 102.71 Bn 94.54 Bn 5.76 Bn
4 Boston Scientific 69.72 Bn 68.51 Bn 3.61 Bn
5 Edwards Lifesciences 49.24 Bn 45.57 Bn 1.29 Bn
6 GE HealthCare Technologies 29.74 Bn 27.67 Bn 1.98 Bn
7 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
8 Dexcom 28.96 Bn 27.84 Bn 750.30 Mn
9 Steris 20.31 Bn 19.88 Bn 697.10 Mn
10 Integra Lifesciences Holdings 1.37 Bn 1.10 Bn 216.98 Mn

Historic Data

Download Data
DateValue
Jun 30, 2022 2.30 Mn
Jun 30, 2022 2.30 Mn
Dec 31, 2020 11.75 Mn
Dec 31, 2020 11.75 Mn
Sep 30, 2020 12.35 Mn
Sep 30, 2020 12.35 Mn
Dec 31, 2014 13.78 Mn
Dec 31, 2014 13.78 Mn